RNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating Biomarkers Submission Guidelines

If you would like to submit a proposal for an oral or poster presentation at this meeting, please click the 'submit abstract' button to view the information required for your submission.

When ready just return to this page and fill out the form accordingly.

All abstracts will be reviewed by the Scientific Advisory Board and applicants will be notified of the result in due course.

Successful applicants will be provided with all necessary information.

Abstract Content:

• Written in English
• Written in the third person
• Include title, name(s) and affiliation(s) of the authors
• Between 100 - 200 words
• Suitable for direct publication in the proceedings pack and on the website
• Related to the subject of the conference

Agenda Topics

• Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development
• Companion Diagnostics in Various Disease Classes
• Autoimmune Disease
• Cancer
• Cardiovascular Disease
• CNS and Neurodegenerative Diseases
• Converting LDTs into FDA-Approved Tests
• Epigenetic Modifications (Hypermethylation of specific Genes) as Biomarkers for Diagnostics Development
• Next-Generation Sequencing (NGS) in Companion Diagnostics
• Potential of microRNAs as Biomarkers for Diagnostics Development
• Protein Biomarkers versus Nucleic Acid Biomarkers for Companion Diagnostics Development
• US vs. EU vs. Asia/Pacific Regulatory Landscape for Companion Diagnostics

Copyrights

The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.